NeoGenomics Laboratories · 3 months ago
Sr. Director, R&D, Heme
Aliso Viejo, CA
Full-time
Onsite
Senior Level, Lead/Staff, Director/Executive
12+ years expNeoGenomics Laboratories is seeking a Senior Director of R&D who will lead the development of next-generation sequencing clinical diagnostic assays for cancer patients, particularly focusing on Hematological assays. The role involves providing scientific and organizational leadership, working closely with lab teams throughout the product lifecycle, and ensuring compliance with regulatory standards.
BiotechnologyGeneticsHealth CareHealth DiagnosticsMedicalPharmaceutical
Responsibilities
Ensure Product Development transpires under levels of design control and development process management appropriate for the end market regulatory environment
Work closely with team members in designing complex NGS assays for clinical oncology
Immaculate attention to detail in analyzing and interpreting NGS data
Strengthens the team’s expertise in heme cancers
Provide leadership and oversight in producing appropriate validation packages for high throughput clinical NGS labs
Presents data and project updates to cross-functional team. Be a driver in aligning the teams to make progress
Prepares high quality technical reports including validation plans, validation reports, reimbursement submission packages
Plan, prepare and produce posters, publications, management presentations
Ability to work in a fast-paced, multi-tasking environment whilst maintaining quality scientific work
Qualification
Required
PhD in genomic science and related field required
A minimum of 12 years' experience in NGS assay development clinical diagnostics
Successful experience in heme assay development, validation and launch
Successful experience in regulatory submissions to MolDx and New York State
Experience in team management
Experience in developing assays under design control and work in cross-functional environment
Ability to travel occasionally as needed
Preferred
Experience in developing assays for minimal residual disease (MRD) is highly desirable
Whole Genome Sequencing assay development experience desirable
Benefits
Highly competitive benefits with a variety HMO and PPO options
Company 401k match
Employee Stock Purchase Program
Tuition reimbursement
Leadership development
16 days of paid time off plus holidays
Wellness courses
Highly engaged employee resource groups
Company
NeoGenomics Laboratories
NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and oncology data solutions.
1001-5000 employees
H1B Sponsorship
NeoGenomics Laboratories has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (10)
2023 (2)
2022 (4)
2021 (3)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$925.9M2021-05-05Post Ipo Equity· $200M
2020-04-30Post Ipo Equity· $125.4M
2020-04-30Post Ipo Debt· $175M
Leadership Team
Ravi Ada
Chief Technology Officer, Informatics Division
George A. Cardoza
Chief Financial Officer
Recent News
2026-01-14
2026-01-13
2026-01-13
Company data provided by crunchbase